Adam Cribbs is an Associate Professor at the University of Oxford as well as being Chief Technology Officer of Caeruleus Genomics. His expertise spans computational biology, immunology, and musculoskeletal biology, and he leads a research group at the Botnar Research Centre that focuses on integrating machine learning with experimental biology to uncover cellular responses to disease.

In his talk, Adam explores the latest advancements in long-read single-cell sequencing and its transformative potential for uncovering novel biological insights. He also provides a critical perspective on the challenges associated with this technology, discussing how these obstacles have been addressed to develop high-quality assays. These methodologies form the foundational technology for targeted discovery within Caeruleus Genomics, driving innovation and accelerating the path from data to therapeutic targets.

On the 24th of September, ATDBio proudly hosted its inaugural Oligonucleotide Symposium at Worcester College, Oxford. The event brought together over 80 attendees from a wide range of disciplines and organisations, both academic and commercial, who were all eager to explore the latest advancements in oligonucleotides and their transformative impact on fields such as diagnostics, therapeutics, and DNA nanotechnology.

If you were unable to make it to the presentation this year and would be interested in attending future events, or if you would be interested in presenting your own work, please reach out to us – we would love to hear from you.